Left ventricular hypertrophy and clinical outcomes in hypertensive patients.

[1]  J. C. Christiansen,et al.  Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. , 2020, Annals of internal medicine.

[2]  G. Parati,et al.  Analysis and interpretation of 24-h blood pressure profiles: appropriate mathematical models may yield deeper understanding. , 2008, American journal of hypertension.

[3]  E. Mannarino,et al.  Left ventricular hypertrophy reversal and prevention of diabetes: two birds with one stone? , 2007, Hypertension.

[4]  A. Covic,et al.  Direct renin inhibitors: the dawn of a new era, or just a variation on a theme? , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  Lucas M Bachmann,et al.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review , 2007, BMJ : British Medical Journal.

[6]  G. Perry,et al.  VALIDD should not invalidate angiotensin-receptor blockers , 2007, The Lancet.

[7]  S. Solomon,et al.  Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial , 2007, The Lancet.

[8]  R. Schmieder,et al.  Renin-angiotensin system and cardiovascular risk , 2007, The Lancet.

[9]  G. Tsivgoulis,et al.  Impact of the time rate of blood pressure variation on left ventricular mass , 2006, Journal of hypertension.

[10]  A. Hall,et al.  The assessment of left ventricular hypertrophy in hypertension. , 2006, Journal of hypertension.

[11]  S. Pede,et al.  Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. , 2006, American journal of hypertension.

[12]  M. Muiesan,et al.  Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy. , 2006, Journal of the American Society of Nephrology : JASN.

[13]  Alice Stanton,et al.  Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.

[14]  G. Tsivgoulis,et al.  Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects. , 2006, American journal of hypertension.

[15]  R. Schmieder.  The role of non-haemodynamic factors of the genesis of LVH. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  P. Gosse,et al.  Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study , 2005, Journal of hypertension.

[17]  M. Drazner,et al.  Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population: The Dallas Heart Study , 2005, Hypertension.

[18]  R. Devereux,et al.  Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. , 2005, American journal of hypertension.

[19]  T. Kahan,et al.  Left ventricular hypertrophy in hypertension: its arrhythmogenic potential , 2005, Heart.

[20]  M. Nieminen,et al.  Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.

[21]  M. Nieminen,et al.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. , 2004, JAMA.

[22]  Arshed A Quyyumi,et al.  Surrogate Markers for Cardiovascular Disease: Functional Markers , 2004, Circulation.

[23]  D. Rizzoni,et al.  Left Ventricular Concentric Geometry During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients , 2004, Hypertension.

[24]  E. Kaplinsky.  Do we understand why regression of left ventricular hypertrophy is beneficial? , 2003, Cardiovascular research.

[25]  R. Devereux,et al.  Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. , 2003, American journal of hypertension.

[26]  M. Nieminen,et al.  Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study , 2003, Circulation.

[27]  M. Mariani,et al.  Blood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive men , 2003, Journal of internal medicine.

[28]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[29]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[30]  T. Kahan,et al.  Relationships between left ventricular mass and the renin–angiotensin system, catecholamines, insulin and leptin , 2002, Journal of internal medicine.

[31]  G. Leoncini,et al.  Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension , 2002, Journal of Human Hypertension.

[32]  I. Kallikazaros,et al.  Microalbuminuria is associated with unfavourable cardiac geometric adaptations in essential hypertensive subjects , 2002, Journal of Human Hypertension.

[33]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[34]  G. Mancia,et al.  Prevalence of Left Ventricular Hypertrophy in Hypertensive Patients Without and With Blood Pressure Control: Data From the PAMELA Population , 2002, Hypertension.

[35]  M. Nieminen,et al.  Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study , 2002, Journal of hypertension.

[36]  Roberto Sega,et al.  Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). , 2002, Hypertension.

[37]  A. Maggioni,et al.  Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. , 2001, Journal of the American College of Cardiology.

[38]  Giuseppe Ambrosio,et al.  Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension , 2001, Circulation.

[39]  R. Devereux,et al.  Effects of Once-Daily Angiotensin-Converting Enzyme Inhibition and Calcium Channel Blockade-Based Antihypertensive Treatment Regimens on Left Ventricular Hypertrophy and Diastolic Filling in Hypertension: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PR , 2001, Circulation.

[40]  P. Okin,et al.  Prognostic implications of left ventricular hypertrophy. , 2001, American heart journal.

[41]  P. Gosse,et al.  Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study , 2000, Journal of hypertension.

[42]  E. Mannarino,et al.  Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension. , 2000, American journal of hypertension.

[43]  J. Pasquié,et al.  Left ventricular adaptation to hypertension and plasma renin activity , 2000, Journal of Human Hypertension.

[44]  C Cosco,et al.  Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. , 2000, Hypertension.

[45]  N. Dali-Youcef,et al.  Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. Parati,et al.  The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension , 1998, Journal of hypertension.

[47]  K. Arakawa,et al.  Plasma renin activity could be a useful predictor of left ventricular hypertrophy in essential hypertensives , 1998, Journal of Human Hypertension.

[48]  K. Hasegawa,et al.  Relationship between left ventricular hypertrophy and renal and retinal damage in untreated patients with essential hypertension. , 1998, Internal medicine.

[49]  G. Hahalis,et al.  Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients. , 1997, Journal of the American Society of Nephrology : JASN.

[50]  W. Aronow,et al.  Association of plasma renin activity and echocardiographic left ventricular hypertrophy with frequency of new coronary events and new atherothrombotic brain infarction in older persons with systemic hypertension. , 1997, The American journal of cardiology.

[51]  R. Schmieder,et al.  Inadequate suppression of angiotensin II modulates left ventricular structure in humans. , 1997, Clinical nephrology.

[52]  A. Menotti,et al.  Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente. , 1997, Giornale italiano di cardiologia.

[53]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[54]  R. Schmieder,et al.  Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. , 1996, Circulation.

[55]  J. Schwartz,et al.  Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. , 1996, Journal of the American College of Cardiology.

[56]  F. Luft,et al.  Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension , 1996, Journal of hypertension.

[57]  G. Reboldi,et al.  Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. , 1995, Journal of the American College of Cardiology.

[58]  G Mancia,et al.  Prognostic value of 24-hour blood pressure variability , 1993, Journal of hypertension.

[59]  P. Palatini,et al.  Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. , 1992, Archives of internal medicine.

[60]  G. Melina,et al.  Prevalence of left ventricular hypertrophy and cardiac arrhythmias in borderline hypertension. , 1992, American journal of hypertension.

[61]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[62]  J. C. Christiansen,et al.  Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. , 1990, Circulation.

[63]  R. Schmieder,et al.  Dietary salt intake. A determinant of cardiac involvement in essential hypertension. , 1988, Circulation.

[64]  G Parati,et al.  Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. , 1987, Journal of hypertension.

[65]  P Kligfield,et al.  Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. , 1985, Journal of the American College of Cardiology.

[66]  W. Kannel,et al.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. , 1969, Annals of internal medicine.

[67]  E. H. Estes,et al.  A point-score system for the ECG diagnosis of left ventricular hypertrophy. , 1968, American heart journal.

[68]  W. Serber,et al.  ELECTROCARDIOGRAPHIC CRITERIA OF LEFT VENTRICULAR HYPERTROPHY , 1952, The American journal of the medical sciences.

[69]  R. Gubner,et al.  ELECTROCARDIOGRAPHIC CRITERIA OF LEFT VENTRICULAR HYPERTROPHY: FACTORS DETERMINING THE EVOLUTION OF THE ELECTROCARDIOGRAPHIC PATTERNS IN HYPERTROPHY AND BUNDLE BRANCH BLOCK , 1943 .

[70]  N. Reichek,et al.  Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential , 2003 .

[71]  D. Levy,et al.  Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity. , 1996, Journal of electrocardiology.

[72]  M. E. Olsen,et al.  Prevalence of left ventricular hypertrophy in a hypertensive population. , 1996, European heart journal.

[73]  D. Arnett,et al.  Greater incidence of electrocardiographic left ventricular hypertrophy in black men than in white men in Evans County, Georgia. , 1992, Ethnicity & disease.

[74]  M. Sokolow,et al.  The ventricular complex in right ventricular hypertrophy as obtained by unipolar precordial and limb leads. , 1949, American heart journal.